S2N Health has filed a notice of an exempt offering of securities to raise $3,109,998.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, S2N Health is raising up to $3,109,998.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Amy Siegel played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About S2N Health
S2N Health empowers medtech success with AI-driven, expert-curated market intelligence. Our AI-powered analytics, superior healthcare data, and deep industry expertise deliver the critical intelligence medtech companies need. Indispensable for launching new products and expanding market share, our end-to-end solution is accessible via web, mobile app, or seamlessly integrated with your CRM.
To learn more about S2N Health, visit http://s2nhealth.com/
Contact:
Amy Siegel, Chief Executive Officer
617-285-4713
https://www.linkedin.com/in/amy-siegel-s2n/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.